頁籤選單縮合
| 題 名 | 臺灣臨床藥學的展望--「藥學4.0」=Clinical Pharmacy in Taiwan: "Pharmacy 4.0" |
|---|---|
| 作 者 | 王慧瑜; 葉明功; 黃耀斌; | 書刊名 | 藥學雜誌 |
| 卷 期 | 32:4=129 2016.12[民105.12] |
| 頁 次 | 頁2-7 |
| 分類號 | 419.21 |
| 關鍵詞 | 物聯網; 雲端藥歷; 藥學4.0; Internet of things; PharmaCloud; Pharmacy 4.0; |
| 語 文 | 中文(Chinese) |
| 中文摘要 | 近四十年來世界藥學的演進,從臨床藥學服務、藥事照護、藥物流行病學的發 展,可知藥事服務已從過去以「藥品」或「疾病」為中心的問題解決模式轉為以 「病人」及「公共衛生」的藥學服務持續發展。近年來在物聯網 (Internet of Things, IOT)、大數據及雲端運算等科技發展之下,激發了「工業4.0」與「醫療4.0」。拜 上述科技進步之賜,台灣藥學發展能否在此科技薰陶下為民眾用藥安全帶來「藥學 4.0」之藥學服務前景? 本文目的在於回顧台灣臨床藥學的發展,展望在日益仰賴雲端科技的今日,期望 台灣的臨床藥學亦能搭上此班科技列車,繪出台灣「藥學4.0」之藍圖。 |
| 英文摘要 | For almost four decades, global pharmaceutical industry has evolved into “patientcentered” and “public-health-centered” pharmaceutical service from “pharmaceuticalcentered” and “disease-centered” service, with a focus on problem solving and sustainable development. In recent years, technology has developed in the form of Internet of Things (IoT), big data, and cloud computing, et cetera, promoting “Industry 4.0” and“Healthcare 4.0.” Given this progression, is it possible that as Taiwanese pharmaceutical industry leverages science and technology, medication safety will transform into “Pharmacy 4.0?” The purpose of this article is to review the development and progress of clinical pharmacy in Taiwan. We expect that the currently increasing dependence on cloud computing will promote the pharmaceutical industry to leverage information technology and draw the blueprint of “Pharmacy 4.0” in Taiwan. |
本系統中英文摘要資訊取自各篇刊載內容。